We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLMA icon
12401
CALL
Olema Pharmaceuticals
OLMA
$1.04B
$75K ﹤0.01%
17,600
-18,700
-52% -$103K
OUST icon
12402
PUT
Ouster
OUST
$2.84B
$75K ﹤0.01%
1,670
-1,380
-45% -$50.9K
RENT
12403
PUT
Rent the Runway
RENT
$122M
$75K ﹤0.01%
545
-310
-36% -$36.4K
SXTC icon
12404
China SXT Pharmaceuticals
SXTC
$1.92M
0
TTI icon
12405
TETRA Technologies
TTI
$1.28B
$75K ﹤0.01%
+18,250
New +$58.3K
UXIN
12406
Uxin Ltd
UXIN
$257M
$75K ﹤0.01%
731
-726
-50% -$82.9K
AFIB
12407
CALL
DELISTED
Acutus Medical Inc
AFIB
$75K ﹤0.01%
54,200
-5,000
-8% -$10.7K
USX
12408
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$75K ﹤0.01%
+19,274
New +$86.4K
APTX
12409
DELISTED
Aptinyx Inc. Common Stock
APTX
$75K ﹤0.01%
32,940
+9,067
+38% +$27.2K
AUTO
12410
CALL
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$75K ﹤0.01%
32,600
-5,900
-15% -$15.8K
FARM
12411
PUT
DELISTED
Farmer Brothers
FARM
$74K ﹤0.01%
10,400
-12,400
-54% -$80.5K
GTBP icon
12412
CALL
GT Biopharma
GTBP
$11.6M
$74K ﹤0.01%
860
-817
-49% -$72.1K
LAB icon
12413
PUT
Standard BioTools
LAB
$310M
$74K ﹤0.01%
20,500
-22,200
-52% -$76.7K
PALI icon
12414
Palisade Bio
PALI
$365M
$74K ﹤0.01%
+93
New +$75.2K
OLOX
12415
CALL
Olenox Industries
OLOX
$4.59M
$74K ﹤0.01%
6
-1
-14% -$11.6K
VRNA
12416
CALL
DELISTED
Verona Pharma
VRNA
$74K ﹤0.01%
+14,900
New +$86.7K
TBSAW
12417
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$74K ﹤0.01%
308,463
-41,536
-12% -$16.7K
TZPSW
12418
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$74K ﹤0.01%
285,060
-101,912
-26% -$42.3K
THER
12419
CALL
DELISTED
THERATECHNOLOGIES INC COM
THER
$74K ﹤0.01%
30,000
-11,500
-28% -$28.4K
BKSY icon
12420
PUT
BlackSky Technology
BKSY
$1.17B
$73K ﹤0.01%
4,813
-10,612
-69% -$222K
CBAT icon
12421
CBAK Energy Technology Ltd
CBAT
$68.5M
$73K ﹤0.01%
56,944
-31,904
-36% -$39.7K
CTSO icon
12422
Cytosorbents Corp
CTSO
$22.7M
$73K ﹤0.01%
22,602
+1,780
+9% +$6.38K
FARM
12423
CALL
DELISTED
Farmer Brothers
FARM
$73K ﹤0.01%
+10,200
New +$66.3K
HOFV
12424
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$73K ﹤0.01%
2,976
+2,054
+223% +$52.8K
JAGX icon
12425
CALL
Jaguar Health
JAGX
$4.1M
0

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.